Literature DB >> 6318573

Differences in myocardial alpha- and beta-adrenergic receptor numbers in different species.

A Mukherjee, Z Haghani, J Brady, L Bush, W McBride, L M Buja, J T Willerson.   

Abstract

In the present study, we tested the hypotheses that 1) different species have different myocardial adrenergic receptor numbers and 2) selected "slow-channel" calcium antagonists compete with alpha-adrenergic antagonists for binding to varying degrees in different species. The data obtained in the present study demonstrate that there is a markedly decreased number of alpha 1-adrenergic and increased number of beta-adrenergic receptors in canine compared with rabbit and rat myocardium. The differences in adrenergic receptor numbers exist without major differences in alpha 1-adrenergic receptor affinity in the species studied. There was no significant difference in left ventricular or plasma catecholamine content between the rat and dog. Selected slow-channel calcium antagonists compete for alpha 1-adrenergic receptor binding in rabbit, rat, and canine myocardium. However, only in rabbit myocardium does verapamil antagonize alpha 1-adrenergic receptor binding at moderate concentrations, whereas verapamil in canine and rat myocardium and 1) 600 in all three species antagonize alpha 1-adrenergic receptor binding only at relatively high concentrations. Nifedipine, a dihydropyridine-type slow-channel calcium antagonist, had no effect on prazosin binding to rat, rabbit, and dog myocardial membranes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318573     DOI: 10.1152/ajpheart.1983.245.6.H957

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  21 in total

1.  Electrophysiologic and inotropic effects of alpha-adrenoceptor stimulation in human isolated atrial heart muscle.

Authors:  U Jahnel; H Jakob; H Nawrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

Review 2.  The use of human cardiac tissue in biophysical research: the risks of translation.

Authors:  Eias Jweied; Pieter deTombe; Peter M Buttrick
Journal:  J Mol Cell Cardiol       Date:  2007-02-09       Impact factor: 5.000

3.  Antagonistic effects of alpha-adrenoceptor blocking agents on arrhythmias, enzyme release, and myocardial necrosis in isolated rat hearts with coronary occlusion and reperfusion.

Authors:  W Bernauer; I Ernenputsch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

Review 4.  [Alpha-adrenoceptors in the myocardium: incidence and functional significance].

Authors:  A Mügge
Journal:  Klin Wochenschr       Date:  1985-11-04

5.  Alpha 1-adrenergic agonists selectively suppress voltage-dependent K+ current in rat ventricular myocytes.

Authors:  M Apkon; J M Nerbonne
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Effects of alpha adrenergic blockade during stellate ganglion stimulation on arrhythmias induced by acute myocardial ischemia in pigs.

Authors:  A R Zou; S R Li; Y Zhang; H Pei
Journal:  J Tongji Med Univ       Date:  1991

7.  Antiarrhythmic and antinecrotic effects of yohimbine stereoisomers in rats during coronary occlusion and reperfusion.

Authors:  W Bernauer
Journal:  Basic Res Cardiol       Date:  1990 Mar-Apr       Impact factor: 17.165

8.  Induction by endogenous noradrenaline of an alpha 1-adrenoceptor-mediated positive inotropic effect in rabbit papillary muscles.

Authors:  Y Hattori; Y Takeda; H Nakaya; M Kanno
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

9.  Contribution of both alpha- and beta-adrenoceptors to the inotropic effects of catecholamines in the rabbit heart.

Authors:  U Jahnel; B Kaufmann; M Rombusch; H Nawrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

10.  Cardiac alpha 1-adrenoceptor densities in different mammalian species.

Authors:  M Steinfath; Y Y Chen; J Lavický; O Magnussen; M Nose; S Rosswag; W Schmitz; H Scholz
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.